Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2026)
Ligand Pharmaceuticals (LGND) posted Current Taxes of $1.9 million for Q1 2026, up 52.78% sequentially from $1.2 million in Q4 2025, and up 4.99% YoY from $1.8 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Current Taxes for 7 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Current Taxes rose 4.99% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 4.99% YoY) and the FY2025 annual result came in at $1.2 million, up 3.34% from the prior year.
- Current Taxes improved to $1.9 million in Q1 2026 per LGND's latest filing, from $1.2 million in the prior quarter.
- Over five years, Current Taxes peaked at $11.4 million in Q2 2023 and troughed at $305000.0 in Q2 2025.
- A 5-year average of $3.2 million and a median of $1.8 million in 2025 frame the typical range for Current Taxes.
- The widest YoY moves for Current Taxes: up 201.08% in 2023, down 87.59% in 2023.
- Over 5 years, Current Taxes stood at $9.7 million in 2022, then slumped by 87.59% to $1.2 million in 2023, then decreased by 0.42% to $1.2 million in 2024, then climbed by 3.34% to $1.2 million in 2025, then soared by 52.78% to $1.9 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $1.9 million, $1.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | 3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 305,000.00 |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Sep 30, 2022 | 9.70 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.80 Mn |
| Sep 30, 2020 | 674,000.00 |
| Sep 30, 2019 | 16.57 Mn |
| Jun 30, 2019 | 47.46 Mn |
| Mar 31, 2019 | 114.00 Mn |